Protecting Biological Inventions – A Well-defined Issue?

Dec 10, 2012

Of the three major sciences – physics, chemistry and biology – the biological sciences are the baby of the family. As such, our understanding of biological systems is less well developed than our understanding of the physical and chemical world around us. Jon Gowshall at Forresters describes how the relationship between science and the law is always a little fraught.     [prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2012/12/1-Protecting-Biological-Inventions-A-Well-defined-Issue.pdf” type=”pdf”]1 Protecting Biological Inventions – A Well-defined Issue?[/prettyfilelink] ...

Read More

IP Audits: A Health Check for your Intellectual Property

Dec 10, 2012

For most biotechnology and pharmaceutical companies, Intellectual Property (IP) is the solid foundation on which the business is built. But when was the last time that you reviewed your IP assets? Elaine Eggington at IP Pragmatics discusses how an IP audit is a valuable tool to look at each potential area of IP, including patent s, trade marks, copyright, branding and confidential know-how (trade secrets) to ensure that they are being identified and managed correctly.   [prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2012/12/2-IP-Audits-A-Health-Check-for-your-Intellectual-Property.pdf” type=”pdf”]IP Audits- A Health Check for your Intellectual Property[/prettyfilelink] ...

Read More

One year after the United Nations Summit on Noncommunicable Diseases (NCDs): New Opportunities and Challenges in the Fight Against NCDs

Dec 10, 2012

This past year has seen tremendous progress on NCDs at the global level, most notably with the adoption of a global target to reduce premature deaths from NCDs including cancer, diabetes, cardiovascular and respiratory disease by 25% by 2025. Julie Torode and Rebecca Morton Doherty at Union for International Cancer Control provide an overview on the tremendous progress on NCDs at the global level.     [prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2012/12/4-One-Year-After-the-United-Nations-Summit-on-Non-communicable-Diseases-NCDs-New-Opportunities-and-Challenges-in-the-Fight-Against-NCDs.pdf” type=”pdf”]One Year After the United Nations Summit on Non-communicable Diseases (NCDs)- New Opportunities and Challenges in the Fight Against NCDs[/prettyfilelink] ...

Read More

RFID and Cold Chain Management

Dec 10, 2012

We would think new technologies in cold chain management would have made great progress in terms of automation in the last years, particularly with the evolution of temperature sensors using RFID communication, but somehow this has not been the case, at least in two of the industries that should benefit the most from it:  biotech and pharma. Alex Guillen at Escort Cold Chain Solutions SA looks into what happened, why it happened, and why we should believe that things would fortunately change.   [prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2012/12/3-RFID-and-Cold-Chain-Management.pdf” type=”pdf”]RFID and Cold Chain Management[/prettyfilelink] ...

Read More

Applications of LIMS to Stability Testing

Dec 10, 2012

Managing pharmaceutical stability testing can be very demanding, especially on small to medium-sized companies developing and producing OTC, generics and new Rx products. Some companies outsource the actual inventory management and testing requirements, but they are still required to track progress and report results as part of their QA or development process and will need to meet guidelines set by regulatory bodies such as the FDA and International Conference on Harmonization. John Boother at Autoscribe Ltd explains how Laboratory Information Management Systems provide a powerful way of managing and reporting the outcome of these studies. [prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2012/12/2-Applications-of-LIMS-to-Stability-Testing.pdf” type=”pdf”]Applications of LIMS to Stability Testing[/prettyfilelink] ...

Read More